Literature DB >> 21511917

15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.

Priyadarshini Raman1, Barbara L F Kaplan, Jerry T Thompson, John P Vanden Heuvel, Norbert E Kaminski.   

Abstract

2-Arachidonyl glycerol (2-AG) is an endogenous arachidonic acid derivative capable of suppressing interleukin (IL)-2 production by activated T cells. 2-AG-mediated IL-2 suppression is dependent on cyclooxygenase-2 (COX-2) metabolism and peroxisome proliferator activated receptor γ (PPARγ) activation. The objective of the present studies was to examine whether 15-deoxy-Δ(12,14)-PGJ(2)-glycerol ester (15d-PGJ(2)-G), a putative metabolite of 2-AG, can mimic the actions of 2-AG on IL-2 regulation through PPARγ activation. 15d-PGJ(2)-G bound PPARγ-ligand binding domain in a PPARγ competitive binding assay. 15d-PGJ(2)-G treatment activated PPARγ in a reporter assay, and PPARγ activation was attenuated when a PPARγ antagonist, 2-chloro-5-nitro-N-4-pyridinylbenzamide (T0070907), was present. 15d-PGJ(2)-G treatment suppressed IL-2 production by activated Jurkat cells, which was partially attenuated when pretreated with T0070907. Moreover, IL-2 suppression was pronounced when 15d-PGJ(2)-G was present 30 min before or after T-cell activation. Concordant with IL-2 suppression, 15d-PGJ(2)-G treatment decreased nuclear factor of activated T cells (NFAT) transcriptional activity in transiently transfected Jurkat cells. It is noteworthy that T0070907 alone markedly increased NFAT reporter activity, suggesting the existence of endogenous PPARγ activation and modulation of NFAT. Because COX-2 metabolism of 2-AG is important for IL-2 suppression, the effect of 2-AG on COX-2 and PPARγ mRNA expression was investigated. 2-AG treatment decreased the up-regulation of COX-2 mRNA after T-cell activation, which suggests negative feedback limiting COX-2-mediated metabolism of 2-AG. PPARγ mRNA expression was increased upon activation, and 2-AG treatment produced a modest decrease in PPARγ mRNA expression. Collectively, our findings suggest that 15d-PGJ(2)-G activates PPARγ to decrease NFAT transcriptional activity and IL-2 expression in activated T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511917      PMCID: PMC3127542          DOI: 10.1124/mol.110.070441

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.

Authors:  T M Willson; J M Lehmann; S A Kliewer
Journal:  Ann N Y Acad Sci       Date:  1996-12-27       Impact factor: 5.691

2.  Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.

Authors:  J M Lehmann; J M Lenhard; B B Oliver; G M Ringold; S A Kliewer
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

3.  Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

Authors:  L Nagy; P Tontonoz; J G Alvarez; H Chen; R M Evans
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.

Authors:  Y Ouyang; S G Hwang; S H Han; N E Kaminski
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

5.  A second endogenous cannabinoid that modulates long-term potentiation.

Authors:  N Stella; P Schweitzer; D Piomelli
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

6.  Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

Authors:  E A Meade; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

7.  The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

Authors:  M Ricote; A C Li; T M Willson; C J Kelly; C K Glass
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

8.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

Authors:  S A Kliewer; S S Sundseth; S A Jones; P J Brown; G B Wisely; C S Koble; P Devchand; W Wahli; T M Willson; J M Lenhard; J M Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.

Authors:  M Lee; K H Yang; N E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

10.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

View more
  17 in total

Review 1.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

3.  Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signaling.

Authors:  Lee C Mangum; Xiang Hou; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; J Allen Crow
Journal:  Biochem J       Date:  2018-02-09       Impact factor: 3.857

4.  15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.

Authors:  Priyadarshini Raman; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

5.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

6.  The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Authors:  D M Kerr; B Harhen; B N Okine; L J Egan; D P Finn; M Roche
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation.

Authors:  Brittany Szafran; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; Barbara L F Kaplan
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-09-25       Impact factor: 3.072

Review 8.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 9.  The role of PPARγ in chemotherapy-evoked pain.

Authors:  Iryna A Khasabova; Virginia S Seybold; Donald A Simone
Journal:  Neurosci Lett       Date:  2021-03-24       Impact factor: 3.046

Review 10.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.